SASH1 Modulates Melanin Synthesis and Melanoma Cell Metastasis via Suppression of the TGF ‐β Signaling Pathway
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.70064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Hongzhou Cui und 10 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Signal Transduction, Melanins, Melanoma, Tumor Suppressor Proteins. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Young Talents in Medical Science and Technology, Health Commission of Shanxi Province, Basic Research Program of Shanxi Province, Natural Science Foundation of Shanxi Province, Bethune Charitable Foundation.
Abstract (Originalsprache)
Dyschromatosis universalis hereditaria (DUH) is characterized by autosomal dominant inheritance and widespread involvement of hyperpigmentation and depigmentation. In our previous study, we identified mutations in the SH3 domain‐containing protein 1 ( SASH1 ) associated with the DUH phenotype in Chinese families and predicted that the SASH1 / THBS1 /TGF‐β1 signaling pathway mediates melanin production and melanocyte transport. However, the molecular regulatory mechanisms remain unclear. By modulating the expression of SASH1 and THBS1 , we assessed the expression of genes within the SASH1 / THBS1 /TGF‐β1 pathway and evaluated cell phenotypes and melanin synthesis in the A375 and PIG1 cell lines. Through in vivo subcutaneous injection of SASH1 knockdown A375 cells into nude mice, we tested whether SASH1 ‐TGF‐β1 signaling may regulate cancer growth. Our findings demonstrated that SASH1 inhibits proliferation, migration, invasion, epithelial–mesenchymal transition, and promotes melanin synthesis through TGF‐β1 signaling, while THBS1 counteracts the increase in TGF‐β1 levels induced by SASH1 knockdown. We further showed that SASH1 suppresses TGF‐β1 through its regulatory effect on THBS1 , thereby inhibiting melanin metastasis and promoting melanin synthesis, which offers potential therapeutic insights into the modulation of TGF‐β1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Dermatology, Jiangsu Province Hospital, Nanjing, China.
- Department of Dermatology, The Second People's Hospital of Changzhi, Changzhi, Shanxi, China.
- Department of Dermatology, Chinese PLA General Hospital (CPLAGH), Beijing, China.
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Hongzhou Cui, Jianhua Hao, Bo Liang
Förderung
- Young Talents in Medical Science and Technology, Health Commission of Shanxi Province
- Basic Research Program of Shanxi Province, Natural Science Foundation of Shanxi Province
- Bethune Charitable Foundation
Zitieren
APA
Cui, H., Hao, J., Wang, Q., Han, J., Liang, H., Zhang, Y., Liang, B., Ge, S., He, H., Ren, X., & Guo, S. (2025). SASH1 Modulates Melanin Synthesis and Melanoma Cell Metastasis via Suppression of the TGF ‐β Signaling Pathway. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.70064
Vancouver
Cui H, Hao J, Wang Q, Han J, Liang H, Zhang Y, et al. SASH1 Modulates Melanin Synthesis and Melanoma Cell Metastasis via Suppression of the TGF ‐β Signaling Pathway. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.70064
BibTeX
@article{Cui2025,
author = {Cui, Hongzhou and Hao, Jianhua and Wang, Qiong and Han, Jie and Liang, Honggang and Zhang, Yingjie and Liang, Bo and Ge, Shanshan and He, Hongxia and Ren, Xiaoli and Guo, Shuping},
title = {SASH1 Modulates Melanin Synthesis and Melanoma Cell Metastasis via Suppression of the TGF ‐β Signaling Pathway},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.70064}
}
EUVIMED